Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
01/2005
01/05/2005CN1559502A Chinese medicinal composition for treating sexual dysfunction
01/05/2005CN1559497A Chinese medicine tighten ointment for treating vagina laxation
01/05/2005CN1559490A Medicine capsule for treating male infertility
01/05/2005CN1559483A Medicinal preparation for treating aphoria
01/05/2005CN1559406A Series medicine prepn. contg. tinidazole used as compound for anti-trichomoniasis and anti-anaerobic former
01/05/2005CN1183247C Membrane destroyed freeze-bried spermatozoa or sperm head and its making method
01/05/2005CN1183132C Tetracyclic azepinoindole compounds as 5-HT receptor ligands
01/05/2005CN1183098C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
01/05/2005CN1182856C External medicine for treating mastopathy and its prepn process
01/04/2005US6838584 Estrogen receptor modulators
01/04/2005US6838476 Imidazoles with anti-inflammatory activity
01/04/2005US6838459 7-alkyl-and cycloalkyl-substituted imidazotriazinones
01/04/2005US6838458 5-(alkylidene-cycloalkyl)-and 5-(alkylidene-heterocyclyl)-pyrazoles
01/04/2005US6838456 Condensed pyridoindole derivatives
01/04/2005US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X
01/04/2005CA2301503C Pharmaceutical compositions for oral administration of molecular iodine
12/2004
12/30/2004US20040267028 Such as 2-amino-1-(2-chlorophenyl)-5-(4-chlorophenyl)-N-cyclohexyl-1H-pyrrole-3-carboxamide hydrochloride
12/30/2004US20040267010 For therapy of central nervous system disorders
12/30/2004US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/30/2004US20040266864 Possess potent serotonin reuptake inhibitory activity, with minimal inhibitory effects on the reuptake of other known monoamines, e.g., norepinephrine or dopamine; also useful for treating or preventing other CNS disorders, cerebrovascular or vascular dysfunctions, sexual dysfunctiions, eating disorders
12/30/2004US20040266812 (5R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinoline-2(1H)-thione
12/30/2004US20040266773 Such as 4-(3-methoxyphenyl)-5-methyl-6-(2-fluorobenzyl)-2-(N-(2-pyridyl)ethyl-N -methyl)ethyl-pyridazin-3-one; drugs/prodrugs for treatment of sex-hormone related conditions in men/women
12/30/2004US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor
12/30/2004US20040266765 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
12/30/2004US20040266750 Beta-lactamyl vasopressin v1aantagonists
12/30/2004US20040266745 Estrogen-gestagen combination preparations and uses thereof
12/30/2004US20040266678 Methods and compositions for treating polycystic ovary syndrome
12/30/2004US20040266025 Screening and treatment methods for prevention of preterm delivery
12/30/2004US20040265968 Tissue plasminogen activator-like protease
12/30/2004US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening
12/30/2004US20040265399 plant extracts used for prevention or treatment of lesions caused by estrogen deficiency
12/30/2004US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
12/30/2004US20040265380 Orodispersible effervescent tablets
12/30/2004US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative
12/29/2004WO2004113381A1 Relaxin superfamily peptide analogues
12/29/2004WO2004113344A1 Methanesulfonic acid salt of pyrazolopyrimidine compound, crystal thereof, and process for producing the same
12/29/2004WO2004113300A1 Novel tricyclic heterocycle compound
12/29/2004WO2004112832A2 Immunogenic compositions comprising multiple gonococcal antigens
12/29/2004WO2004048419A9 Method of classifying, purifying and using fenugreek seeds
12/29/2004WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
12/29/2004WO2002043648A3 Compounds active at the glucocorticoid receptor ii
12/29/2004EP1491524A2 Selective androgen receptor modulators and methods of use thereof
12/29/2004EP1491236A1 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same
12/29/2004EP1491207A1 Novel screening method
12/29/2004EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004EP1490688A1 Novel compositions and methods in cancer associated with altered expression of prdm 11
12/29/2004EP1490393A1 11beta-substituted 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring
12/29/2004EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
12/29/2004EP1490324A2 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors
12/29/2004EP1490121A1 Drug delivery particle
12/29/2004EP1490120A1 Embolization
12/29/2004EP1490081A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
12/29/2004EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
12/29/2004EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004EP1490041A1 Treatment of female sexual dysfunction
12/29/2004EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
12/29/2004EP1257539B1 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
12/29/2004EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin
12/29/2004EP1135123B1 Use of isatin derivatives as ion channel activating agents
12/29/2004EP0986545B1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
12/29/2004EP0830130B9 Tnf-alpha converting enzyme
12/29/2004EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
12/29/2004CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004CN1558724A Herbal nutraceutical formulation for females/expectant mothers and its process of preparation
12/29/2004CN1557485A Application of gene recombined human lysozyme in eliminating pathogenic microorganism infection
12/29/2004CN1557477A Sterile and freeze dried hypophysin preparation for injection and its preparing process
12/29/2004CN1557461A Chinese medicinal preparation for treating climacteric metancholia of qi and blood deficiency type and preparing process thereof
12/29/2004CN1557443A 'Fufukang' Chinese traditional medicine preparation and preparing process thereof
12/29/2004CN1557438A Medical capsule for treating pelvic inflammatory disease and its preparing process
12/29/2004CN1557422A Chinese medicinal preparation for treating gynopathy
12/29/2004CN1557412A Chinese medicine composite preparation for treating blood syndrome of woman
12/29/2004CN1557404A Medicine for treating hyperplasia of mammary glands and preparation method thereof
12/29/2004CN1557373A Chinese medicine preparation for treating climacteric metancholia of liver depression and qi stagnation
12/29/2004CN1557372A Chinese medicine preparation for treating climacteric metancholia of liver-yang hyperactive type and its preparing process
12/29/2004CN1557359A Mammary gland lobular hyperplasia treating plaster and its preparing process
12/29/2004CN1557342A Antisenescent and sexual function improving preparation
12/29/2004CN1557333A Chinese traditional medicine composition and its preparation and quality control method thereof
12/29/2004CN1557311A Fibrauretine capsule tablet and its preparation method
12/29/2004CN1557295A Gynecopathy therapeutic drug
12/29/2004CN1557294A Oryzanol containing soft capsule preparation method
12/29/2004CN1557288A Lactic acid , glycerin formulation for female vagina acidity, humidity improvement
12/29/2004CN1181887C Recombinant gamma-interferon for preventing and treating cow's recessive mammitis
12/29/2004CN1181865C Quick dissolving sensitive layer for treating gynecopathy
12/29/2004CN1181824C Minocycline vaginal effervescent tablets
12/29/2004CA2534748A1 Relaxin superfamily peptide analogues
12/28/2004US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004US6835744 3,3-substituted indoline derivatives
12/28/2004US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004US6835716 Bactericides, antiprotozoa agents
12/28/2004US6835388 Mixing a compound which acts as a local anesthetic with physiological salt; placing formulation in a catheter; administering formulation into uterine cavity of woman with a catheter; pertubating the formulation into peritoneal cavity
12/28/2004US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/23/2004WO2004110461A1 Treatment of symptoms associated with bacterial vaginosis
12/23/2004WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004WO2004094451A3 8$G(B)-VINYL-11$G(B)-($G(V)-SUBSTITUTED)ALKYL-ESTRA-1,3,5(10)-TRIENES
12/23/2004WO2004071390A3 Piperazine-2-carboxamide derivatives
12/23/2004WO2003089002A9 Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
12/23/2004US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence